URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...
Francis Medical today announced the first commercial procedure using its Vanquish water vapor ablation system.
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once will face a recurrence within five years. A new treatment, known as salvage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results